Adage Capital Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $106M | Buy |
|
|||||
|
2025
Q2 | $68.3M | Buy |
|
|||||
|
2025
Q1 | $32.9M | Sell |
|
|||||
|
2024
Q4 | $90.6M | Buy |
|
|||||
|
2024
Q3 | $55.1M | Buy |
|
|||||
|
2024
Q2 | $60M | Sell |
|
|||||
|
2024
Q1 | $124M | Buy |
|
|||||
|
2023
Q4 | $35M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $39.2M | Sell |
|
|||||
|
2023
Q1 | $43.8M | Buy |
|
|||||
|
2022
Q4 | $29.4M | Sell |
|
|||||
|
2022
Q3 | $41.4M | Sell |
|
|||||
|
2022
Q2 | $56.8M | Sell |
|
|||||
|
2022
Q1 | $76.7M | Sell |
|
|||||
|
2021
Q4 | $86.2M | Sell |
|
|||||
|
2021
Q3 | $75.8M | Sell |
|
|||||
|
2021
Q2 | $70M | Sell |
|
|||||
|
2021
Q1 | $58.2M | Buy |
|
|||||
|
2020
Q4 | $63.1M | Sell |
|
|||||
|
2020
Q3 | $55.6M | Sell |
|
|||||
|
2020
Q2 | $49.4M | Sell |
|
|||||
|
2020
Q1 | $61.8M | Buy |
|
|||||
|
2019
Q4 | $40.5M | Sell |
|
|||||
|
2019
Q3 | $50.1M | Sell |
|
|||||
|
2019
Q2 | $46.7M | Sell |
|
|||||
|
2019
Q1 | $71M | Buy |
|
|||||
|
2018
Q4 | $31.3M | Sell |
|
|||||
|
2018
Q3 | $40.4M | Sell |
|
|||||
|
2018
Q2 | $73.6M | Sell |
|
|||||
|
2018
Q1 | $103M | Buy |
|
|||||
|
2017
Q4 | $61.7M | Buy |
|
|||||
|
2017
Q3 | $24.7M | Sell |
|
|||||
|
2017
Q2 | $62.4M | Buy |
|
|||||
|
2017
Q1 | $19.5M | Sell |
|
|||||
|
2016
Q4 | $28.8M | Sell |
|
|||||
|
2016
Q3 | $100M | Sell |
|
|||||
|
2016
Q2 | $106M | Sell |
|
|||||
|
2016
Q1 | $99.1M | Sell |
|
|||||
|
2015
Q4 | $99.6M | Buy |
|
|||||
|
2015
Q3 | $84.6M | Buy |
|
|||||
|
2015
Q2 | $59.4M | Buy |
|
|||||
|
2015
Q1 | $30.9M | Buy |
|
|||||
|
2014
Q4 | $21.1M | Buy |
|
|||||
|
2014
Q3 | $12.1M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $11.8M | Buy |
|
|||||
|
2013
Q2 | $6.2M | Buy |
|